Breaking News!
Watson reaches patent settlement for Actos generic
Share this story:
106 Views
Rate This!
Loading ...
topix-com
MORRISTOWN,A N.J. Watson Pharmaceuticals and Takeda Pharmaceuticals North America have settled a patent litigation case concerning a diabetes drug, Watson announced Wednesday.
Reproduced under the Fair Use exception of 17USC107
2 months ago
Loading ...Related Stories
- 65 CLICKSTakeda Responds To FDA Advisory Committee Recommendation
- 103 CLICKSPfizer to co-promote Takeda’s pioglitazone Hcl in China to treat type 2 diabetes (PharmaBiz)
- 82 CLICKSPREVIEW-UPDATE 1-Will FDA approve Amylin, Lilly diabetes drug?
- 60 CLICKSOramed Pharmaceuticals To Present At The 70th Scientific Sessions Of The American Diabetes Association
Responses //
0
Add Something
Post Your Response
Post Your Story
